Frequency of Laboratory Tests
JH · Effective Oct 1, 2015
14 active Medicare policies list 83721, and 6 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J15 · Effective Oct 5, 2015
JE · Effective Jun 1, 2016
JF · Effective Jun 1, 2016
JJ · Effective Oct 5, 2015
JM · Effective Oct 5, 2015
J5 · Effective Jun 16, 2016
J8 · Effective Jun 16, 2016
6 policies from 6 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 83721 |
|---|---|---|
| Screening for Lipid Disorders | Jul 14, 2023 | Covered |
| Policy | Effective | Status of 83721 |
|---|---|---|
| Attention Deficit Hyperactivity Disorder Assessment and Treatment | Not recorded | Covered |
| Policy | Effective | Status of 83721 |
|---|---|---|
| Biomarker Testing in Risk Assessment and Management of Cardiovascular Disease | Jul 15, 2026 | Covered |
JL · Effective Jan 1, 2023
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2025
J5 · Effective Oct 1, 2026
| Policy | Effective | Status of 83721 |
|---|---|---|
| Biomarker Testing in Risk Assessment and Management of Cardiovascular Disease | Jul 15, 2026 | Covered |
| Policy | Effective | Status of 83721 |
|---|---|---|
| Biomarker Testing in Risk Assessment and Management of Cardiovascular Disease | Jul 15, 2026 | Covered |
| Policy | Effective | Status of 83721 |
|---|---|---|
| Biomarker Testing in Risk Assessment and Management of Cardiovascular Disease | Jul 15, 2026 | Covered |